Dr. Wei Liu 刘伟
Chief Physician, Associate Professor
Department of Hepatobiliary and Pancreatic Surgery I, Peking University Cancer Hospital, Beijing
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Surgical treatment of colorectal cancer liver metastases, primary liver cancer, intrahepatic cholangiocarcinoma, pancreatic cancer, and gallbladder cancer.
Dr. Liu holds a medical doctorate in oncology from Peking University Health Science Center (2013). A Chief Physician and Associate Professor at Peking University Cancer Hospital, Dr. Liu focuses on clinical and basic research in hepatobiliary and pancreatic tumors. Dr. Liu has published extensively in international and domestic journals and participated in translating the 2015 Clinical Practice Guidelines for Pancreatic Cancer.
Professional roles
- Youth Committee Member, Colorectal Tumor Professional Committee, Chinese Medical Doctor Association
- Youth Committee Member, Colorectal Cancer Liver Metastasis Committee, China International Exchange and Promotion Association for Medical and Healthcare
- Youth Editorial Board Member, Electronic Journal of Liver Cancer
Name order: in Chinese the family name comes first (Liu Wei). Papers usually list the name as Wei Liu or Liu W.
Selected publications
90 papers on PubMed matched by name and affiliation; 25 as first or senior author since 2016. Most recent first- or senior-author papers:
- BMC Gastroenterol, 2026 (senior author): Effectiveness and safety of tenofovir amibufenamide in the treatment of chronic hepatitis B patients with low-level viremia: a retrospective real-world study. PubMed 42106615
- Bioengineering (Basel), 2025 (first author): Design and Performance Assessment of a High-Resolution Small-Animal PET System. PubMed 41155117
- Front Pharmacol, 2025 (senior author): Effectiveness and safety of tenofovir amibufenamide and tenofovir alafenamide in treating elderly patients diagnosed with decompensated hepatitis B cirrhosis: a retrospective cohort study. PubMed 40248094
- Nutr Clin Pract, 2024 (senior author): Evaluation of different screening tools as the first step of the GLIM framework: A cross-sectional study of Chinese cancer patients in an outpatient setting. PubMed 38161144
- Ann Surg Oncol, 2023 (first author): Recurrence Prediction by Circulating Tumor DNA in the Patient with Colorectal Liver Metastases After Hepatectomy: A Prospective Biomarker Study. PubMed 37219651
- BMC Surg, 2023 (first author): Tumor attachment to Major intrahepatic vascular for Colorectal liver metastases. PubMed 37353772
- Eur J Oncol Nurs, 2023 (senior author): The effect of Chinese culture-adapted dignity therapy on advanced cancer patients receiving chemotherapy in the day oncology unit: A quasi-experimental study. PubMed 36889242
- Chin J Cancer Res, 2023 (first author): Management guidelines for preventing exposure to antineoplastics. PubMed 36910857
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital. This name is shared by other researchers, so we checked that most papers list this doctor's hospital and department.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion